CarboDB Lipoarabinomannan 1010
From DrugPedia: A Wikipedia for Drug discovery
[edit] Carbohydrate Name
Lipoarabinomannan
[edit] Carbohydrate Class
Miscellaneous
[edit] Source Microbe
Mycobacterium tuberculosis
[edit] Basic Structure
Mycobacterial lipoarabinomannan is a phosphatidylinositol anchored lipoglycan that consists of an α1-->6 linked backbone, substituted to varying degrees at position 2 with single α-Man residues, and directly attached to position 6 of the myo-inositol of a phosphatidylinositol (PI) anchor
[edit] Proposed functions
Reported to suppress T cell proliferation and to interfere with gamma interferon-mediated activation of macrophages. Other reported effects include inhibition of protein kinases, inhibition of the synthesis of mRNA encoding IL-2, IL-5, and granulocyte-macrophage colony stimulating factor (GM-CSF) in human T cells and activation of the complement cascade
[edit] Antigenic Nature used to produce antibodies
Heat killed Mycobacterium tuberculosis
[edit] Carrier Name
nil
[edit] Conjugation Method
nil
[edit] Antibodies
SMITB14
[edit] Antibody type and class
IgG1
[edit] Assay System
N\A
[edit] Cross-reactivity
SMITB14 bound to whole M. tuberculosis bacteria (H37Rv and Harlingen strains) as well as to the attenuated BCG, but not to other species such as Escherichia coli strains of various O serotypes, Streptococcus pneumoniae isolates, strains of Salmonella, Yersinia enterocolitica and Y. pseudotuberculosis and Nocardia sp.
[edit] Proposed epitopes
Arabinomannan portion of the antigen
[edit] Proposed Utility
This antibody might be involved in blocking of mycobacterial invasion. SMITB14 may prevent the uptake of M. tuberculosis through receptor(s) that facilitate bacterial survival and growth.
